A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury (RISCIS)
The purpose of this trial is to evaluate the efficacy and safety of riluzole in the treatment of patients with acute SCI.
Investigator: Shekar N. Kurpad, MD, PhD
Status: Currently enrolling
TBI, Exception from Informed Consent
The research studies blood flow in aneurysm for the selection of treatment. (NIH RO1: HL115267)
The database is designed specifically to serve as a screening and recruitment tool for stroke researchers in the greater Milwaukee Area, matching stroke survivors willing to contribute to science as research participants with study coordinators seeking to populate their studies with individuals meeting their particular inclusion/exclusion criteria.
This is a randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson’s disease.
This is a randomized, double-blind, placebo-controlled, phase IIa, parallel-group, two-cohort study to define the safety, tolerability, clinical and exploratory biological activity of the chronic administration of Nilotinib in participants with Parkinson’s disease (PD).
Parkinson’s Disease, PD, Nilotinib
The purpose of this study is to understand what gene mutations can contribute to ALS. Understanding the gene mutations could lead to insight into future therapies.
Amyotrophic Lateral Sclerosis, ALS, gene mutations, genetic
The purpose of this study is to test what changes happen in participants with ALS that can be seen in the blood and urine and what changes are unique to ALS. These changes are called biomarkers.
Amyotrophic Lateral Sclerosis, ALS, Primary Lateral Sclerosis, PLS, Progressive Muscular Atrophy, PMA, Motor Neuron Disease, Biomarker
This randomized, double-blind, controlled, parallel group study evaluates the efficacy and safety of FLX-787-ODT for treatment of muscle cramps in adult subjects with motor neuron disease.
Motor Neuron Disease, Muscle cramps, FLX-787-OD
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) (FORTITUDE-ALS)
This is a phase 2, multicenter, double-blind, randomized, dose-ranging, placebo-controlled study to evaluate the efficacy, safety and tolerability of CK-2127107 in patients with amyotrophic lateral sclerosis (ALS).
Amyotrophic Lateral Sclerosis, ALS, CK-2127107
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
This is a multicenter, double-blind, placebo-controlled study to assess the efficacy and safety of H.P. Acthar® Gel in the treatment of subjects with amyotrophic lateral sclerosis (ALS). MNK14042068
Amyotrophic Lateral Sclerosis, ALS, Acthar
MRI Study of Intervertebral Disc Degeneration: Evaluation of the Vascular Characteristics in Patients with Chronic Low Back Pain due to Degenerative Disc Disease
Low back pain, degenerative disc disease, healthy volunteers
Spinal Cord Injury
Brain Tissue Bank